Jump to content

Wikipedia:Articles for deletion/Ken Blum: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Line 5: Line 5:
Professor with lots of journal citations but does this pass [[WP:PROF]]? was tagged speedy on notability grounds, tag was removed by creator, and re-tagged, I declined and broght it here instead [[User:Carlossuarez46|Carlossuarez46]] 22:45, 22 August 2007 (UTC)
Professor with lots of journal citations but does this pass [[WP:PROF]]? was tagged speedy on notability grounds, tag was removed by creator, and re-tagged, I declined and broght it here instead [[User:Carlossuarez46|Carlossuarez46]] 22:45, 22 August 2007 (UTC)


Most certainly, this posting meeting WP:PROF on notability grounds. The criteria, as I understand it, is:
Most certainly, this posting meeting WP:PROF on notability grounds. The criteria, as I understand it, is:


1. The person is regarded as a significant expert in his or her area by independent sources.
1. The person is regarded as a significant expert in his or her area by independent sources.

Revision as of 23:22, 22 August 2007

Ken Blum (edit | talk | history | protect | delete | links | watch | logs | views) – (View log)

Professor with lots of journal citations but does this pass WP:PROF? was tagged speedy on notability grounds, tag was removed by creator, and re-tagged, I declined and broght it here instead Carlossuarez46 22:45, 22 August 2007 (UTC)[reply]

Most certainly, this posting meeting WP:PROF on notability grounds. I am in the midst of adding all of the citations as I just added this wiki today. The criteria, as I understand it, is:

1. The person is regarded as a significant expert in his or her area by independent sources. 2. The person is regarded as an important figure by independent academics in the same field.


Dr. Blum has been recognized in many different ways. Here are some examples:

ELECTED: Publication Committee - Alcoholism: Clinical and Experimental Research Nomination Committee - Research Society on Alcoholism Scientific Advisory Committee - International Neurotoxicology Congress, Italy Council Member - Gordon Research Conferences Chairman - Steering Committee for Program on Gordon Research Conferences on Alcohol Chairman, First International Congress on Neurogenetics of Alcoholism Chairman, Fifth World Congress on Biological Psychiatry, Alcoholism, Florence, Italy Chairman, Alcohol Research, Gordon Research Conference (1978, 1884). Chairman, Psychoneurogenetics, Gordon Research

AWARDS: 1970 Awarded Colonel of The State of Tennessee by Governor Winford Dunn 1974-76 National Institute of Drug Abuse Carrier Teacher Award 1972 American Chemical Society Speaker Award 1988 Visiting Scientist, Douglas Hospital Research Centre, McGill University 1988 Finalist, Mind Science Foundation "Imagineer Award" 1990 John B. Sullivan Presidential Excellence Award for Treatment and Research 1990 Nursing Health Consultants Outstanding Achievement Award 1994 YMCA Achievement Award

INVITED SPEAKER: Presented over 300 lectures on "Social Pharmacology" across approximately 40 states in America, as well as Europe, Scandinavia, Mexico, Canada, USSR, and the Orient. 1974 Lecture Opener for Southwestern Teachers Commission on Drug Abuse, Knoxville, TN 1976 Program Speaker, Annual Meeting of the California Medical Association, San Francisco, CA 1976 Speaker and Workshop Coordinator, Anesthesiology Conference, University of Kansas Medical Center, Kansas City, KS 1976 Speaker, Ohio Drug Abuse Institute, Columbus, OH 1977 Task Force Member, National Free Clinic, National Drug Abuse Conference, San Francisco, CA 1979 Speaker, Annual Texas Commission on Alcoholism Institute, Austin, TX 1979 Speaker, Workshop on Drugs of Abuse, Big Springs, Texas Hospital Scientific seminar on "Alcohol Research" presented to staff, Toxicology Branch, Food and Drug Administration, Washington, D.C., Harvard Medical School, NIDA-ARC, as well as over 50 research seminars to major universities in the U.S and abroad. RESEARCH: 1974 Chairman, Behavioral Pharmacology, Session at ASPET Meeting in Montreal, Canada 1976 Guest Speaker, Seventh Technical Review on Drug Interaction, National Institute on Drug Abuse, Washington, D.C. 1977 Chairman, Alcohol Session, ASPET Meeting, Columbus, OH 1977 Chairman, Marijuana Session, National Drug Abuse Conference, San Francisco, CA 1977 Task Force Member, Psychiatry Task Force, National Drug Abuse Conference, San Francisco, CA 1977 Task Force Member, Research Task Force, National Drug Abuse Conference, San Francisco, CA 1978 National Chairperson, Pharmacology and Research Task Force, National Drug Abuse Conference 1979 General Chairman, Gordon Research Conference on Alcohol 1979 Chairman, International Congress of Neurotoxicology, "The Biological Basis for Alcoholism," Varese, Italy 1979 Chairman, Pharmacology Alcohol Sessions - Federation meetings, Dallas, TX 1982 General Chairman, Gordon Research Conference on Alcohol 1996 General Chairman, Gordon Research Conference on Psychoneurogenetics Presented seminars on alcoholism research at major universities, governmental agencies and sponsored societies including: Special Guest Invitation of Correo Medico Magazine Conference on Drug Dependence. "The Psychogenetic Theory of Drug Seeking Behavior,” Milan, Italy, 1982. PAGE 10 Selected as Scientific Leader of delegation to Union of the Soviet Union Socialist Republic (Russia) (U.S. Professional Seminars, Inc.) on "Addictions," 1984. Keynote Speaker - "Genotype Theory of Alcohol Seeking Behavior." Current Research Trends, San Francisco, CA, July, 1985. Workshop Presenter - "Alcoholism: Research into Biogenetics and Cure." Texas Commission on Alcoholism, Austin, TX, Summer Alcohol Studies Institute, August, 1985. Symposia Presenter - "Animal and Human Evidence for the Genotype Theory in Alcohol Seeking Behavior." International IV World Congress on Biological Psychiatry," Philadelphia, PA, September, 1985. Invited Lecturer - "Biogenetics of Alcoholism." Friends Hospital, Philadelphia, PA, October, 1985. Presenter - "Alcoholism - A Genotypic Disease." First World Congress on Drug and Alcohol Abuse, Tel Aviv, Israel, December, 1985. Scientific Leader - U.S. Exchange Tour of China. Invited by the Peoples Republic of China. China Association for Science and Technology (sponsor), March 18 to April 5, 1986. Grand Rounds - “Alcoholism: Searching the Solution." University of Arkansas, College of Medicine, Department of Psychiatry, Little Rock, AK, November, 1985. Grand Rounds - "Noval Neurochemical Approach to Alcoholism." The University of Texas Health Science Center, Department of Psychiatry, Dallas, TX, November, 1986. Keynote Speaker - "Designer Drugs." North Texas Psychiatric Society, Dallas, TX, November, 1986. Scientific presentation - Institute of Clinical Research of Montreal, Canada, April, 1987. Seminar - Douglas Hospital Research Centre, Montreal, Canada, April, 1987. Seminar - Addiction Research Foundation, Toronto and The University of Toronto, Canada, April, 1987. Chairman - Neuotoxicology Congress, Alcoholism Session, Italy, June, 1987. Invited Speaker - Second-West, "Assault on Alcoholism: A neurobiological Disease," Phoenix, AZ, March, 1988. Seminar - National Drug Research Centre and University of Malaysia, Dept. of Pharmacology, March, 1988. Selected Participant and Symposium Speaker - XVI C.I.N.P. Congress, München, Germany, 1988. One of six Americans lectured at the first Soviet-American Conference on Alcoholism, Moscow, 1989. Co-chairman on Alcoholism Session - Fifth World Congress on Biological Psychiatry, Italy, 1991. Keynote Speaker, Pacific Chemical Dependency Institute, Hawaii, 1991. Invited Speaker, National Academy of Science, East Berlin, 1991. Chairman, C.I.N.P., XVII Molecular Genetics of Compulsive Diseases, Nice, 1992. Plenary Speaker, 25th Anniversary Conference Haight Ashbury Medical Free Clinic, 1992. Chairman, "International Congress on Amino Acid Therapy", Crete, Greece, 1993 Chairman, World Congress in Psychiatry - Molecular Genetics Symposium, Rio de Janeiro, June 6-13, 1993 European Society of Neuroscience, Biological Psychiatry Symposium, Vienna, Austria, July 1994 Chairman, Molecular Genetic Symposium- Biological Psychiatry, Nice, France, 1996 Talks not yet given: American Society of Addiction Medicine, Association for Applied Psychophysiology and Biofeedback Invited speaker- International Meeting on “Implications of Comorbidity for Etiology and Treatment of Neuropsychiatric Disorders “ - October 19-23. Mazagon (Huelva) Spain, 2005. OTHER: 1961 Bigelow Research Fellowship Award, Columbia University 1966-1968 American Foundation for Pharmaceutical Education Fellow Award, New York Medical College 1967 National Science Foundation Summer Fellowship Award, New York Medical College 1969 Personalities of the South, Listed 1970 American Chemical Society Tour Speaker Plaque Award 1970 National Association of Retail Druggist Citation of Honor 1971-1972 Two-Thousand Men of Achievement, Listed 1973 Intercontinental Biographical Association 1974-1977 Career Teachers Award in Substance Abuse - NIDA 1975 & 1982 Who's Who in the South and Southwest 1976 Personalities of the South, listed in Bicentennial Edition 1979 National Free Clinic Council, Inc., Board of Directors, Southwest Region Representative 1979 Who's Who in the South and Southwest 1979 Citation of Honor, Alamo Area Council of Governments (AACOG) 1979 Certificate of Merit for Substance Abuse Service to the Community, St. Mary's University, San Antonio, TX 1979 Lions Club Speaking Service Award 1979-1986 American Men and Women in Science 1979 & 1982 Gordon Research Award 1981 Humanitarian Award - Columbian University (College of Pharmacy 20th Year Reunion) 1984 & 1985 Who's Who in Frontiers of Science and Technology 1985 Expert Drug Consultant for Scott Forseman, New Health Text 1985 Distinguished Contributor to the Definition of Alcoholism for the World Book Encyclopedia (To be published in 1989 edition) 1985-present Six scientific patents issued U.S. Patent Office (Principal and Co-Inventor), Two Canadian Patents, eleven European Patents issued, One Japanese Patent pending, One PCT patent pending in 45 countries, one USA patent Pending, One Provisional patent pending. 1987 Contributor to 1987 Health and Medicine Annals - World Book. 1987 Selected Distinguished Speaker List - Evaluation Research Associates, Syracuse, NY 1988 Issuance, USA Patent #4,701,421 1989 Mind Science Foundation Award 1989 Issuance, USA Patent #4,844,866 (see other patents). 1990 Addictives Treatment Directory 1990 Who's Who in American Inventors 1992 Honorary Diplomat, Addictions Board of Certification, American Academy of Addictionology & Compulsive Disorders 1998 Honorary Doctorate in Humane Letters, St. Martins College, Milwaukee WI.


3. The person has published a significant and well-known academic work. An academic work may be significant or well known if, for example, it is the basis for a textbook or course, if it is itself the subject of multiple, independent works, if it is widely cited by other authors in the academic literature[1].

Dr. Blum has extensive publications, as well as work that has been the basis for textbooks and course work.


4. The person's collective body of work is significant and well-known.

Dr. Blum's collective body of work is very significant and well-known, and further study by NIDA and other bodies at NIH have validated his initial findings relating to the DRD2 receptors and the corresponding genes.

5. The person is known for originating an important new concept, theory or idea which is the subject of multiple, independent, non-trivial reviews or studies in works meeting our standards for reliable sources.

Dr. Blum is known for originating the idea that alcoholism is associated with the Dopamine D2 Receptor gene as well as the concept of Reward Deficiency Syndrome with has been published in the Journal of the Royal Society of Medicine - a peer review medical journal.


6. The person has received a notable award or honor, or has been often nominated for them.

Awards and honors previously mentioned.

Brianmeshkin 23:18, 22 August 2007 (UTC)[reply]